Skip to main content
Clinical Trials/NCT02070627
NCT02070627
Completed
Phase 1

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy Sub-Study

Ohio State University1 site in 1 country6 target enrollmentJuly 2013

Overview

Phase
Phase 1
Intervention
Indocyanine Green (ICG)
Conditions
Acute Cholecystitis
Sponsor
Ohio State University
Enrollment
6
Locations
1
Primary Endpoint
Adverse events related to use of indocyanine green (ICG)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to evaluate an imaging system using Indocyanine Green (ICG) to assist in real-time identification of anatomy during cholecystectomy (gallbladder removal) in patients with acute cholecystitis and cholangitis. We propose to define the effectiveness of NIRF-C in identifying the cystic duct junction during cholecystectomy.

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
August 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Narula, Vimal K, MD

Associate Professor

Ohio State University

Eligibility Criteria

Inclusion Criteria

  • Age 18-89
  • Planned laparoscopic cholecystectomy

Exclusion Criteria

  • Inability to provide informed consent
  • Allergy to ICG, iodine, and/or shellfish
  • Lactating

Arms & Interventions

NIRF-C and IOC

Each enrolled subject will undergo injection with indocyanine green (ICG), intraoperative near infrared fluorescence cholangiography (NIRF-C) and standard of care intraoperative cholangiography.

Intervention: Indocyanine Green (ICG)

NIRF-C and IOC

Each enrolled subject will undergo injection with indocyanine green (ICG), intraoperative near infrared fluorescence cholangiography (NIRF-C) and standard of care intraoperative cholangiography.

Intervention: Near Infrared Fluorescence Cholangiography (NIRF-C)

Outcomes

Primary Outcomes

Adverse events related to use of indocyanine green (ICG)

Time Frame: Injection to 2 wk follow-up

Adverse events related to the use of ICG from the time of injection through the initial post-operative clinic visit will be recorded and assessed.

Procedure time

Time Frame: Intraoperative

The time it takes to perform near infrared fluorescence cholangiography and standard of care intraoperative cholangiography will be compared.

Anatomic identification with NIRF-C and IOC

Time Frame: Intraoperative

Anatomic identification with near-infrared fluorescence cholangiography and standard of care intraoperative cholangiography (IOC) will be used to calculate a 95% confidence interval for the effectiveness of this modality.

Study Sites (1)

Loading locations...

Similar Trials